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Evaluation of Rapid Syphilis Testing Using the 
Syphilis Health Check in Florida, 2015–2016 
_______________________________________________________________________________ 
 
Jennifer Richards, MPH, DrPH student; James Matthias, MPH; Charlotte Baker, DrPH, 
MPH, CPH; Craig Wilson; Thomas A Peterman, MD, MSC; C Perry Brown, DrPH, MSPH; 
Matthew Dutton, PhD; Yussif Dokurugu, DrPH, MPH 
________________________________________________________________________________ 
ABSTRACT 
The Syphilis Health Check (SHC) had low estimated specificity (91.5%) in one Florida county. We investigated use of 
SHC by a range of Florida publicly-funded programs between 2015 and 2016 to estimate specificity, positive predictive 
value (PPV), field staff acceptance, and impacts on programmatic outcomes. All reported SHC results were extracted 
from routinely collected program data. Field staff were surveyed about SHC’s utility. Analyses investigated differences 
between SHC and traditional syphilis testing outcomes. Of 3,630 SHC results reported, 442 were reactive; 92 (20.8%) 
had prior diagnoses of syphilis; 7 (1.6%) had no further testing. Of the remaining 343; 158 (46.0%) were confirmed 
cases, 168 (49.0%) were considered false-positive, and 17 (5.0%) were not cases but not clearly false-positive. Estimated 
specificity of SHC was 95.0%. Overall, 48.5% of positives became confirmed cases (PPV). PPV varied according to 
prevalence of syphilis in populations tested. Staff (90%) thought SHC helped identify new cases but expressed concern 
regarding discordance between reactive SHC and lab-based testing. Programmatic outcomes assessment showed shorter 
time to treatment and increased numbers of partners tested for the SHC group; these enhanced outcomes may better 
mitigate the spread of syphilis compared to traditional syphilis testing alone, but more research is needed.   
 
Richards, J., Matthias, J., Baker, C., Wilson, C., Peterman, T.A., Brown, C.P., Dutton, M., & Dokurugu, Y. (2019). 
Evaluation of rapid syphilis testing using the syphilis health check in Florida, 2015–2016. Florida Public Health 
Review, 16, 106-119.  
____________________________________________________________________________________________
BACKGROUND 
     The U.S. Food and Drug Administration granted 
the first-ever Clinical Laboratory Improvement 
Amendments waiver for a rapid treponemal syphilis 
screening test, Syphilis Health Check, in December 
2014 (FDA, 2014). Accurately identifying new cases 
of syphilis, administering timely treatment, and 
securing timely partner notification for testing and 
treatment are cornerstones of successful public health 
interventions to control the spread of syphilis.  
     The SHC may facilitate these interventions, but 
very few studies have investigated its performance in 
the field. One small cohort study found that sensitivity 
was 71.4% and specificity was 91.5%, significantly 
lower than the >98% specificity reported for SHC 
(Matthias et al., 2016).  Findings from a larger United 
States cohort study using 2014 – 2016 data to 
investigate the performance of SHC showed that 
sensitivity ranged from 88.7% to 95.7% and 
specificity ranged from 93.1% to 93.2%, depending on 
the method of confirmatory test result consensus used 
(Pereira et al., 2018). Other studies have found mixed 
results with a range of sensitivity (61.1% to 92.0%), 
specificity (92.7% to 99.6%), and positive predictive 
value (9.4% to 97.5%) (Jafari et al., 2013; Seña, 
White, & Sparling, 2010; Toskin et al., 2017).  
     Few studies have assessed the acceptability of the 
SHC among healthcare workers and patients (Ansbro 
et al., 2015; Swartzendruber, Steiner, Adler, Kamb, & 
Newman, 2015), and none have been from the United 
States. A rapid point of care test could reduce clinic 
waiting time, allow same-day treatment, facilitate 
outreach testing, and allow substitution of finger-stick 
for venipuncture (Ansbro et al., 2015; Swartzendruber 
et al., 2015). Faster identification of new syphilis cases 
could decrease time to treatment and facilitate partner 
treatment.  
 
Purpose 
     Florida has multiple syphilis testing sites across the 
state and routinely captures testing and case 
management information, including time to treatment 
and numbers of partners named, tested, infected, and 
treated. We aimed to describe the results of SHC 
testing in Florida after a state-wide implementation 
and the impact on programmatic outcomes. Moreover, 
we surveyed the staff that used SHC to identify 
benefits and challenges to using it in the field.    
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METHODS 
Data Extraction and Study Population 
     All records for adults tested with SHC from 
08/01/2015 through 12/31/2016 were extracted, de-
identified, and compiled. The SHC was performed by 
health department staff who had been trained in 
administering the SHC. Test settings varied based on 
program needs. Data included syphilis testing 
location, test type, test results, case/non-case 
determination, treatment, and partner services 
outcomes. We excluded persons who required testing 
for congenital syphilis or neurosyphilis, as the SHC 
test is not appropriate for determining these types of 
syphilis. This was a program evaluation of standard 
routine public health practices using de-identified 
programmatic data. Thus, it was determined not to be 
human subjects research.  
 
SHC Reactivity Rate Determination  
     All 67 Florida health departments were given the 
opportunity to receive SHC kits for rapid syphilis 
testing free of charge. Each health department self-
selected whether to use the SHC at its site or not. If a 
health department did request SHC kits to use, the only 
stipulation was that the health department had to report 
all SHC test results to the health department of the 
county in which the patient resides. Training of field 
staff for use of the SHC was provided by the SHC 
distributor. All tests reported in this study were done 
by health departments. A total of 35 Florida counties 
conducted SHC testing. For inter-county comparison, 
data was stratified by volume of SHC tests given for 
the top 11 SHC-using counties and combined for the 
small volume remaining in the other 24 counties. The 
top 11 counties, in order of greatest number of SHC 
tests conducted to the least, were Orange, Miami-
Dade, Escambia, Lee, Alachua, Polk, Duval, Leon, 
Hillsborough, Palm Beach, and Brevard.  
     The performance of the SHC was investigated at 
both statewide and county levels. Variables of interest 
were SHC test result status (positive or negative), 
agreement or discordance between SHC results and 
traditional testing (non-treponemal and/or treponemal) 
results, new syphilis cases identified from SHC 
testing, and new syphilis cases treated as the result of 
positive SHC test results.  
     We excluded from the analyses any SHC test 
results that were done on persons with a history of past 
syphilis or when there were no associated 
confirmatory test results. The prevalence of syphilis 
among persons appropriately tested was estimated as 
the number of new syphilis cases reported divided by 
the number of persons tested. The Council for State 
and Territorial Epidemiologists (CSTE) case 
definition for reported syphilis cases was used to 
determine new cases.(Sosa, 2017) Specific to this 
study, new cases were assessed and classified by local 
program staff. For this evaluation, SHC reactive tests 
without both a reactive treponemal and non-
treponemal test or a diagnosis of primary syphilis by a 
provider were considered inconclusive. Positive 
predictive value (PPV) was calculated after excluding 
persons with inconclusive results on additional testing. 
Thus, PPV was the new cases divided by the sum of 
the new cases plus the false positives, times 100. 
Specificity was estimated by considering all negative 
SHC to be true negatives. No false negative SHC were 
identified because persons who tested negative on the 
SHC were not retested. The specificity is the number 
of true negatives divided by the sum of the true 
negatives plus the false positives, times 100.    
 
Programmatic Outcomes Assessment Comparing SHC 
with Traditional Syphilis Testing  
     In order to identify programmatic benefits of the 
SHC, we conducted analyses comparing cases 
identified using the SHC administered by health 
department staff with cases identified at public health 
departments using traditional syphilis testing in the 11 
Florida counties that did the most SHC testing during 
the defined study period for 2015 and 2016. Treatment 
data were collected by health department staff from 
syphilis investigations conducted by healthcare 
providers. Timeliness of treatment was calculated by 
subtracting the recorded date of treatment from the 
date of specimen collection. The outcome variables 
were timeliness of treatment, number of named 
partners, number of named partners tested, number of 
named partners infected, and number of infected 
partners treated (see Variables of Interest, Appendix 
1).  
 
Survey Interviews of Field Staff  
     Field staff interviews were conducted from 
09/27/2017 through 10/19/2017 using a 27-question 
survey instrument to assess the value of the SHC as a 
screening test and its effectiveness as a tool to prevent 
the spread of syphilis (see Survey Instrument, 
Appendix 2). Survey participants were not chosen at 
random, rather they were chosen based on expertise 
with the SHC. Participants consisted of one program 
manager and those field staff who had the most 
experience administering the SHC test as identified by 
the Florida Department of Health STD program. The 
roles served by these field staff included syphilis 
testing, supervising staff who conduct syphilis testing, 
and those involved in follow-up partner services. Field 
staff participating in the survey were representative of 
the top 11 SHC-using Florida counties: Orange, 
Miami-Dade, Escambia, Lee, Alachua, Polk, Duval, 
Leon, Hillsborough, Palm Beach, and Brevard. For 
consistency, all surveys were conducted by one 
research team member via telephone interview.  
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Data Analysis 
     Statistical analyses were done using SAS 9.4 (Cary, 
NC) and OpenEpi.com (Dean, Sullivan, & Soe, 2011). 
Chi Square tests were used to determine statistically 
significant differences between groups. Generalized 
Linear Models (GLM) were used to determine whether 
statistically significant differences existed between the 
means of programmatic outcomes for the SHC Testing 
Group and the Traditional Testing Group. 
 
RESULTS 
SHC Reactivity Rate Determination  
     For 08/01/2015 through 12/31/2016, there were 
3630 SHC tests reported, 442 (12.0%) were positive, 
3168 (87.0%) were negative, and 20 (1.0%) were 
inconclusive. Of the 442 positive SHC results, 92 
(20.8%) had a prior diagnosis of syphilis (even though 
a screening tool was used to minimize SHC testing in 
this group), 7 (1.6%) had missing information 
regarding prior diagnosis of syphilis or had no further 
confirmatory testing, leaving 343 (77.6%) who had no 
prior diagnosis of syphilis and had further testing. Of 
these 343, 158 (46.0%) were considered true positives 
based on non-treponemal reactive rapid plasma reagin 
(RPR) and treponemal (primarily treponemal enzyme 
immunoassays [EIA]) testing (157) or a negative RPR 
with a reactive treponemal test and a lesion consistent 
with primary syphilis (Figure 1). Treatment was 
documented for 157 (99.4%) of the 158 new cases. 
There were 168 (49.0%) false positives that were not 
reported as new cases and had negative results on the 
RPR (138), treponemal test, or both (29). Finally, 17 
(5.0%) of the 343 with reactive SHC were considered 
inconclusive because they were not reported as a new 
case of syphilis but had reactive results on the RPR (7), 
treponemal test, or had the combination of reactive 
treponemal test /negative RPR (9). The prevalence of 
new syphilis in the population tested (after removing 
those with inconclusive SHC results, prior syphilis, or 
no further testing) was 4.5% (158/[3630-20-92-7]). 
Specificity was estimated to be 95% using the false 
positives (168) and all 3168 who tested negative on 
SHC (3168/[168+3168], x 100). The PPV was 
estimated from the true and false positives to be 48.5% 
(158/[158+168]) (Table 1).  
The largest number of SHCs were done in Orange 
County, followed by Miami-Dade, Escambia, Lee, 
Alachua, Polk, Duval, Leon, Hillsborough, Palm 
Beach, and Brevard. These counties accounted for 
approximately 93.0% of all SHC testing conducted 
and approximately 90.0% of all new cases of syphilis 
that were identified using the SHC test in Florida 
during the time period. The statewide prevalence of 
newly identified syphilis (those cases found using the 
SHC test) in the populations tested was estimated to be 
4.5% (range of 0.4% to 28.2% in all SHC using 
counties). Statewide, 48.5% of persons with a positive 
SHC had newly diagnosed syphilis (the positive 
predictive value). By county, this ranged from 8.0% to 
100%, depending on the prevalence of syphilis among 
those tested, and was lowest in the two highest SHC 
volume counties. Per county, the specificity ranged 
from 90.1% to 100% among the 11 most SHC-using 
counties (Table 1).  
 
Programmatic Outcomes Assessment Comparing SHC 
with Traditional Syphilis Testing  
     The sample size of syphilis cases used in the 
analyses of programmatic outcomes was n=1644 and 
included those who: (a) were tested for syphilis using 
SHC or traditional testing during the study period, (b) 
were from the top 11 SHC-using Florida counties, (c) 
had no prior diagnosis of syphilis, and (d) had public 
initial lab ordering providers. Of these 1644 cases, 93 
were from the SHC testing group and 1551 were from 
the traditional testing group. In the SHC testing group, 
all 93 cases were treated. In the traditional testing 
group, 37 of the 1551 cases (2.4%) were not treated or 
were otherwise lost to follow-up.  
 
Timeliness of treatment. Persons tested with SHC were 
more likely to receive prompt treatment than persons 
from the traditional testing group [same day (RR = 
1.88; 95% CI, 1.54-2.30), 7 days or less (RR = 1.63; 
95% CI, 1.44-1.84), 14 days or less (RR = 1.19; 95% 
CI, 1.10-1.28), and 30 days or less (RR = 1.06; 95% 
CI, 1.03-1.10)]. The average time to treatment among 
those treated was 7.3 days for the SHC group versus 
13.0 days for the traditional testing group (F=3.55, 
p=0.06) (Table 2).  
           
Partner Elicitation, Testing, and Treatment. Among 
new cases, patients tested with the SHC were more 
likely to name partners than patients who had 
traditional testing (RR = 1.44; 95% CI, 1.27-1.63) and 
they named a higher average number of partners (1.3 
compared to 0.8 partners) (F=16.79, p<.0001) (Table 
2). Patients who had SHC testing were more likely to 
have at least one named partner tested than patients 
from the traditional testing group (RR = 1.45; 95% CI, 
1.23-1.72) and they had a higher average number of 
named partners tested (0.9 partners compared to 0.6 
partners) (F=20.35, p<.0001) (Table 2). The SHC 
testing group was more likely to have named partners 
identified as infected than was the traditional testing 
group (RR = 2.34; 95% CI, 1.82-3.01) and had a 
higher average number of named partners identified as 
infected (0.5 compared to 0.2 partners infected) 
(F=40.20, p<.0001), even when controlling for those 
who named at least one partner (0.8 compared to 0.5) 
(F=19.13, p <.0001) (Table 2). The SHC testing group 
was more likely to have infected partners subsequently 
treated than was the traditional testing group (RR = 
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2.29; 95% CI, 1.77-2.96) and had a higher average 
number of named infected partners treated (0.5 
compared to 0.2) (F=37.58, p<.0001) (Table 2).   
 
Survey Interviews of Field Staff  
     A total of 20 field staff surveys were conducted. 
These field staff included one test administrator and 
one program manager from each of the high-volume 
SHC-using programs (with one of the test 
administrators and one of the program managers 
representing two of the high-volume counties that are 
adjacent to each other). The 20 survey participants 
reported that the training they received from the SHC 
distributor for using the SHC test prepared them to 
confidently administer the test. Most said the SHC test 
was easy to use (15/20), test results were easy to read 
(16/20), and that they had confidence in the accuracy 
of the results (12/20). Strengths of the SHC included: 
(a) highly appropriate to use in outreach settings (6/20, 
30%), and (b) quick results were appreciated by staff 
and patients (8/20, 40%). Respondents described 
twenty-two examples in which the SHC test was 
particularly helpful to field staff and/or patients and 
are elucidated here: (a) confirming syphilis in the 
presence of symptoms (2/20), (b) quickly putting 
patients’ minds at ease when SHC results were 
negative or making patients aware of the need for 
further testing when SHC results were positive (3/20), 
(c) testing people who preferred a finger-stick or were 
afraid of needles (16/20), and (d) quickly identifying 
an infected pregnant patient who was HIV positive 
(1/20).  
     Settings that survey respondents thought were most 
appropriate for using the SHC test were health 
department clinics, outreach sites, physician’s offices, 
emergency rooms, community-based organizations, 
jails, STD clinics, and any sites that offer free services. 
Most respondents thought the SHC test was a 
beneficial addition to traditional syphilis testing 
(16/20). When asked about the percentage of clients 
who had a difficult time understanding what a positive 
SHC test result meant, the answers varied widely from 
0.0% to 80.0%, with the majority being 10.0% or less. 
The respondents further stated that this was “about the 
same” amount as clients who also had difficulty 
understanding results from traditional syphilis testing.  
     The weaknesses reported for the SHC test were that 
test kits expired too quickly (2/20) and that the pipet 
included in the test kit was flimsy, making it difficult 
to get a blood sample (7/20). The most common 
complaint about the SHC test was field staff were 
concerned there may have been too many “false 
positive” results (14/20).  
Most respondents said they did not notify named 
partners of clients with positive SHC test results until 
they have the confirmatory test results back (14/20). 
Replies from the 20 respondents about beginning 
treatment for syphilis, based on positive test results 
from the SHC alone, were mixed; five were “highly 
likely” to begin treatment, five were “likely” to begin 
treatment, one was “neutral,” three were “unlikely,” 
and six were “very unlikely.” Those who were “highly 
likely” or “likely” to begin treatment reserved this 
only for clients who also had symptoms of syphilis or 
had a confirmed syphilis exposure.  
Most respondents said that positive SHC test results 
presented no more of a challenge for counseling or 
administering treatment than positive results from 
traditional syphilis testing (17/20). Most respondents 
also said that the quick results from the SHC test 
provided a better service than traditional testing for 
clients in settings other than the health clinics (17/20). 
For syphilis testing in settings other than the health 
clinic (such as outreach sites), most respondents said 
they prefer to use the SHC test because a larger volume 
of testing can be done, and it helps to mitigate the 
spread of syphilis, especially in jails, where there is a 
readily available audience for testing participation 
(13/20). Respondents’ opinions varied regarding the 
use of the SHC test in the health clinic settings; five 
preferred using the SHC test alone, four preferred 
using traditional testing alone, six preferred using both 
the SHC test and traditional testing together, three had 
no preference, and two were neutral.  
 
DISCUSSION 
Using data collected from testing in a wide variety 
of settings in Florida, we estimate the specificity of the 
SHC was 95.0%, as in many cases the SHC was 
compared against a non-treponemal result. Although 
the specificity was fairly consistent in the 11 different 
counties studied, the proportion of persons with 
positive tests who were diagnosed as having syphilis 
(predictive value of a positive test) varied, mostly due 
to differences in the prevalence of syphilis among 
those tested (0.4% to 28.2%). Compared to the 
traditional testing group, the SHC testing group had 
more timely treatment, more partners named, and 
more partners identified as infected. These enhanced 
outcomes may be due to quick SHC test results 
allowing for more accurate recall in naming partners, 
as well as enabling Disease Intervention Specialists 
(DIS) to promptly notify these named partners (Hoots 
et al., 2014; Rudy et al., 2012).  
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Table 1. Syphilis Health Check (SHC) Tests Conducted, those Leading to New Syphilis Casesa, and 
Estimated Specificity by County 
County  
Total 
SHCb 
Tests 
Conducted  
Total 
Negative 
SHCb  
Total Reactive SHCb 
Positive 
Predictive 
Value (PPV)  
Estimated 
Specificitye 
   
Total 
Positivesac 
SHCb  
New 
Syphilis 
Casesa  
False 
Positivesd    
 1 - Orange 1042  936 72  20  52 27.8% 94.7% 
 2 - Miami-
Dade 
568  530 28  2  23 8.0% 95.8% 
 3 - 
Escambia 
471  401 60  32  26 55.2% 93.9% 
 4 - Lee 450  426 22  5  17 22.7% 96.2% 
 5 - Alachua 202  179 17  4  13 23.5% 93.2% 
 6 - Polk 162  150 8  6  1 85.7% 99.3% 
 7 - Duval 130  78 39  33  2 94.3% 97.5% 
 8 - Leon 100  90 9  1  8 11.1% 91.8% 
 9 - 
Hillsborough 
95  64 29  22  7 75.9% 90.1% 
10 - Palm 
Beach 
87  73 12  3  7 30.0% 91.3% 
11 - Brevard 75  41 15  14  0 100% 100% 
All other 
testing 
counties (n 
=24) 248  200 32  16  12 57.1% 94.3% 
Total for 
entire state 
of Florida 3630  3168 343  158  168 48.5% 95.0% 
aFor those who had no prior diagnosis of syphilis 
bSyphilis Health Check 
cExcludes those with inconclusive SHC (20), prior syphilis (92), or no further testing after a positive test (7) 
dExcludes those with inconclusive test results (17) 
eEstimated Specificity = True Negatives/(True Negatives + False Positives)  
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Table 2. Comparison of Group Averages for Programmatic Outcomes Between the SHCa Testing Group 
and the Traditional Testing Group 
Programmatic Outcome 
SHCa Testing 
Group 
n=93b 
Traditional Testing 
Group 
n=1551b 
p-value 
Time to Treatment Among Those Who Were 
Treated, (days, mean) 
7.3 13.0 (n=1514) 0.0597 
Named Partners, (mean) 1.3 0.8 <0.0001 
Partners Tested, (mean) 0.9 0.6 <0.0001 
Named Partners Tested Among Those Who Named 
Partners, (mean) 
1.3 (n=70) 1.1 (n=811) 0.0632 
Partners Infected, (mean) 0.5 0.2 <0.0001 
Partners Infected Among Those Who Named 
Partners, (mean) 
0.8 (n=58) 0.5 (n=665) <0.0001 
Infected Partners Treated, (mean) 0.5 0.2 <0.0001 
aSyphilis Health Check 
 
bThis sub-group includes only the top 11 SHC using counties, subjects with no prior diagnosis of syphilis, and only 
those subjects who had a public initial lab ordering provider 
	
Figure	1.	Flow	Chart	for	Syphilis	Health	Check	Positive	Results	Leading	to	New	Syphilis	Cases	
A	flow	chart	showing	SHCa	positive	test	results	leading	to	new	syphilis	cases	from	08/01/2015	through	
12/31/2016.	
aSyphilis	Health	Check,	bDiagnosis,	cRapid	Plasma	Reagin,	dOutlier	case	conclusively	identified	as	primary	
syphilis	
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Additionally, a greater sense of urgency for both 
patient and practitioner may exist when SHC results 
are positive in the presence of signs and symptoms 
and/or a known syphilis exposure. This scenario might 
create expediency for an intervention conversation at 
this initial encounter to educate the patient and 
possibly administer treatment. Our findings suggest 
the SHC could improve syphilis control efforts, 
however the administration and selection for SHC 
testing was not randomly assigned and outcomes were 
assessed against a small sample size of newly detected 
cases. Going forward, a more rigorous evaluation 
could help determine if the SHC test truly does 
improve these outcomes.  
     Our estimated specificity is higher than the 
specificity estimated in a previous investigation in 
Florida (Matthias et al., 2016). A low specificity could 
be a serious deterrent to using the SHC in low 
prevalence settings. However, one study concluded 
that even in low prevalence settings, screening with 
rapid syphilis testing remains cost-effective and less 
expensive than use of the RPR (Mallma et al., 2016). 
Before implementing the SHC, program 
administrators should discern the potential value of the 
test, based on the specific characteristics of their 
individual programs. Given the relatively stable 
specificity, but highly variable PPV, the benefits of the 
SHC will depend on the population tested.  
    Field staff liked the SHC test, with a majority citing 
practicality for use by non-laboratory health care 
workers, flexibility for use in non-traditional settings, 
and faster test results that allowed quicker 
identification and treatment of new syphilis cases. 
They also believed that use of the SHC test could help 
reduce the spread of syphilis. Field staff also reported 
concerns about test kits expiring too quickly, 
challenges in sample collection, and accuracy of 
results. This information helps to fill in previously 
recognized gaps in understanding of the performance, 
usefulness, and limitations of the SHC (Seña et al., 
2010).  
     This study had several limitations. The sensitivity 
of the SHC test could not be determined because 
specimens with negative SHC results were not re-
tested with other tests to see if any infections were 
missed. The estimated specificity and “false positives” 
compared results from a treponemal-based rapid test 
to, in many cases, only a non-treponemal test. 
Although these persons would be unlikely to have 
syphilis, some probably had treponemal antibody due 
to a previous infection. These issues may limit the 
confidence in the specificity estimate. Information 
from the survey interviews of field staff may be unique 
to Florida’s syphilis prevention program, and therefore 
may not be generalizable to other programs.  
 
 
Implications for Public Health Practice 
     The SHC test appears to be an effective screening 
tool that provides rapid and reliable test results, 
especially in the presence of symptoms, that may 
facilitate same-day treatment or shorter overall time to 
treatment. The rapid results may enhance timely 
partner notification by reducing delays in new case 
identification and reporting, as well as facilitate 
successful partner services interactions. In addition, it 
was highly acceptable to both healthcare workers and 
patients. Our findings about the impact of the SHC on 
these important outcomes are promising. Further 
research is needed to continue to define the benefits 
and limitations of this new test.      
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Appendix 1. Variables of Interest Regarding Programmatic Outcomes  
Variable Name Variable Type Definition 
SHCa Testing Group Categorical New cases of syphilis identified 
with the SHCa test 
Traditional Testing Group Categorical New cases of syphilis identified 
with traditional syphilis tests 
Timeliness of Treatment Categorical and continuous Categorical – mutually inclusive 
time interval cut points: 
Zero days to treatment 
7 days or less to treatment 
14 days or less to treatment 
30 days or less to treatment 
Over 30 days to treatment or no 
treatment given 
Continuous – time to treatment 
in days 
Number of Named Partners Categorical and continuous Categorical – stratified 
responses as “Yes” (partners 
were named) or “No” (zero 
partners were named) 
Continuous – numbers of 
partners named 
Number of Named Partners 
Who Were Tested 
Categorical and continuous Categorical – stratified 
responses as “Yes” (named 
partners were tested) or “No” 
(zero named partners were 
tested) 
Continuous – numbers of named 
partners tested 
Number of Named Partners 
Who Were Infected 
Categorical and continuous Categorical – stratified 
responses as “Yes” (named 
partners were infected) or “No” 
(zero named partners were 
infected) 
Continuous – numbers of named 
partners infected 
Number of Named Partners 
Who Were Infected and Treated 
Categorical and continuous Categorical – stratified 
responses as “Yes” (named 
partners were infected and 
treated) or “No” (zero named 
partners were infected and 
treated) 
Continuous – numbers of named 
partners infected and treated 
This table describes the variables of interest used to analyze programmatic outcomes. 
aSyphilis Health Check 
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Appendix 2. 
Field Staff Questionnaire – Assessment of the Rapid Syphilis Health Check 
Name of Staff Member   __________________________________________ 
County Name __________________________________________________ 
Instructions:  
This survey is being done to obtain the perspectives of field staff about syphilis testing using the 
Rapid Syphilis Health Check (RSHC). We would like to know what you think about the 
implementation of syphilis testing using the RSHC in your field setting to help determine best 
practices and effectiveness of this test.  
 
Section A. 
Please complete the following questions. 
 
1.  What is your primary profession or role? (Check one response only) 
     □ Nurse             □ Phlebotomist 
     □ Disease Intervention Specialist          □ Lab Technician 
     □ Nurse Practitioner           □ Health Support Technician 
     □ Area Manager            □ STD Supervisor 
     □ Other ___________________________ 
 
2.  What is your role in syphilis testing? (Check all that apply) 
□ Management or administrative role in syphilis testing 
□ Supervise staff conducting syphilis testing 
□ Conduct syphilis testing 
□ Provide health care services for patients who have received syphilis testing/screening 
□ Teach other providers or students about syphilis testing 
□ Follow-up partner services 
□ Other (Specify) _______________________________________________________________ 
 
 
Section B. 
When answering the following questions, think of the value of the RSHC as a screening test 
for syphilis.  
 
1.  Did the training you received for the RSHC test prepare you to confidently administer this test 
to those seeking syphilis testing? 
□ Yes      □ No    
□ If you answered “no”, please explain: 
______________________________________________________________________________
______________________________________________________________________________ 
 
2.  Would you rate the RSHC test: 
□ Easy to use    □ Difficult to use   □ Neutral  
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If you answered “difficult”, please explain: 
______________________________________________________________________________
______________________________________________________________________________ 
 
3.  Did you experience any challenges in administering the RSHC test? 
□ Yes    □ No 
 
If you experienced any challenges, please list them here: 
______________________________________________________________________________
______________________________________________________________________________ 
 
Please list any suggestions you may have to address these challenges: 
______________________________________________________________________________
______________________________________________________________________________ 
 
4.  Would you rate RSHC test results: 
□ Easy to read/interpret □ Difficult to read/interpret  □ Neutral 
 
If you answered “difficult”, please explain: 
______________________________________________________________________________
______________________________________________________________________________ 
 
5.  Do you have confidence in the accuracy of the RSHC test results? 
□ Yes   □ No 
 
Please explain your answer, for either “Yes” or “No”: 
______________________________________________________________________________
______________________________________________________________________________ 
 
6.  Were there any strengths of the RSHC test as a screening test? If so, please list them: 
______________________________________________________________________________
______________________________________________________________________________   
 
7.  Were there any weaknesses of the RSHC test as a screening test? If so, please list them: 
______________________________________________________________________________
______________________________________________________________________________ 
 
8. Was there a situation(s) in which you found the RSHC to be particularly helpful? 
□ Yes     □ No     □ Unsure/don’t know 
 
Please explain your answer: 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
9.  What settings are most appropriate for use of the RSHC test? (Check all that apply) 
□ Health Department Clinic  □ Outreach site □ Physician’s office 
□ Emergency Room   □ Community-based Organization 
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□ Other: ______________________________________________________________________ 
 
10.  Has the use of the RSHC test been a beneficial addition to traditional syphilis testing, or 
would the traditional testing alone suffice? 
□ The RSHC has been a beneficial addition 
□ The traditional syphilis testing alone would suffice 
 
Please explain your answer: 
______________________________________________________________________________
______________________________________________________________________________ 
 
11.  In regard to syphilis testing, what is your opinion about patients’ preferences regarding 
having a finger-stick versus having a tube of blood drawn?  
□ Patients prefer a finger-stick   
□ Patients prefer having a tube of blood drawn  
□ Patients have no preference 
□ Unsure/don’t know 
 
12.  In communicating results of the RSHC test to the patient, what percentage of patients would 
you say had issues in understanding what a positive screening test means? 
___________________% 
 
13.  Would you say this percentage is higher or lower than traditional syphilis testing? 
□ Higher than traditional testing 
□ Lower than traditional testing 
□ About the same as traditional testing 
 
 
Section C. 
When answering the following questions, think of the value of the RSHC as a tool in your 
arsenal against the spread of syphilis. 
1.  As part of the protocol for RSHC testing, a Rapid Syphilis Test Risk Assessment 
questionnaire is completed on all clients to determine whether they are at risk for syphilis. Would 
you say that this questionnaire adequately provides this information?  
□ Yes   □ No   □ Neutral  □Unsure/don’t know 
 
Please explain your answer: 
______________________________________________________________________________
______________________________________________________________________________ 
 
2.  As part of the protocol for RSHC testing, a Rapid Syphilis Test Risk Assessment 
questionnaire is completed on all clients to determine whether they have a history of syphilis. 
Would you say that this questionnaire adequately provides this information?  
□ Yes   □ No   □ Neutral  □Unsure/don’t know  
 
Please explain your answer: 
______________________________________________________________________________
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______________________________________________________________________________ 
 
3.  Is the Rapid Syphilis Test Risk Assessment (described in questions 1 and 2 above) helpful, as  
it pertains to the effectiveness in identifying new syphilis cases?  
□ Yes   □ No   □ Neutral 
 
Please explain your answer: 
______________________________________________________________________________
______________________________________________________________________________ 
 
4.  Were partners of patients with positive RSHC test results notified before the patient got 
confirmatory results from traditional syphilis testing?        
□ Yes                                                            □ No   □ Unsure/don’t know 
 
If you answered “yes”, did the RSHC test increase the timeliness of partner notification versus 
using traditional syphilis testing alone? 
□ Yes     □ No      □ Made no difference  □ Unsure/don’t know 
 
5.  How likely are you to begin treatment for syphilis based on a positive RSHC test result 
(before getting confirmatory test results)? (Check one response only) 
□ Highly likely □ Likely □ Neutral □ Unlikely □ Very unlikely 
 
6.  Did positive RSHC test results present more of a challenge to you in how to proceed with 
counseling/administering treatment compared to having a positive result from traditional testing?  
□ Yes, it presented more of a challenge 
□ No, it did not present more of a challenge 
□ Neutral, it made no difference either way 
 
Please explain your answer:   
______________________________________________________________________________
______________________________________________________________________________ 
 
7.  Does the RSHC test, with same day results, (versus traditional syphilis testing, with a 3 – 7 
day wait time for results) better serve the patient population that receives syphilis testing in 
settings other than the health clinic?  
□ Yes   □ No   □ Neutral  □ Unsure/don’t know  
 
Please explain your answer: 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
8.  For syphilis testing in the health clinic, would you prefer to use the RSHC test or traditional 
syphilis testing alone? 
□ RSHC □ traditional syphilis testing alone □ No preference □ Unsure/don’t know 
 
Please explain your answer: 
______________________________________________________________________________ 
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______________________________________________________________________________ 
 
9.  For syphilis testing in settings other than the health clinic (such as jail or outreach sites), 
would you prefer to use the RSHC test or traditional syphilis testing alone? 
□ RSHC □ traditional syphilis testing alone □ No preference □ Unsure/don’t know 
 
Please explain your answer: 
______________________________________________________________________________ 
______________________________________________________________________________ 
 
Section D.  
 
1.  List any benefits or positive outcomes that have resulted from the implementation of the 
RSHC test in your work setting. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
2.  List any problems or negative outcomes that have resulted from the implementation of the 
RSHC test in your work setting. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
3.  Share any other comments about the RSHC test. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
 
Thanks for your help!
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